Helping NET Cancer patients get a timely diagnosis,
the best care and ultimately a cure
If you don’t suspect it you can’t detect it
84% of NET patients
Their needs for information about treatment
options were not met at the time of diagnosis.
58% of NET patients are
diagnosed at an advanced stage
How Can I Help?
Between July 1st and September 7th, the Canadian neuroendocrine cancer community will work together in an effort to raise $100,000 in the 2020 Neuroendocrine cancer research fundraising campaign, HOOFING IT Across Canada for Neuroendocrine Cancer Research. In this...read more
NETRF just published its Annual Report to detail accomplishments for a record-setting year with hallmark progress in overcoming a major obstacle in NET research - reliable NET cell lines. The publication looks at the scientific milestones in developing laboratory...read more
The American Association of Cancer Research (AACR) has awarded Yoshiyuki Majima, President of PanCan Japan and INCA Secretary, its prestigious Distinguished Public Service Award (PSA). It is the first PSA to be given to an advocate from Japan according to AACR. INCA...read more